103 related articles for article (PubMed ID: 25748637)
1. Cellular and biological evaluation and diagnostic immunohistochemistry of cytokeratin 15/19 expression in distinguishing cutaneous basal cell carcinoma.
Ziari K; Behdad B; Mohammadshahi A; Pirasteh HR; Sharifi MD; Dadpay M
Biologicals; 2015 May; 43(3):181-5. PubMed ID: 25748637
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of cytokeratin 15, cytokeratin 19, follistatin, and Bmi-1 in basal cell carcinoma.
Kim HC; Sohng SH; Shin DH; Choi JS; Bae YK
Int J Dermatol; 2016 Jan; 55(1):36-44. PubMed ID: 26739632
[TBL] [Abstract][Full Text] [Related]
3. Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.
Choi CW; Park HS; Kim YK; Lee SH; Cho KH
J Dermatol; 2008 Aug; 35(8):499-502. PubMed ID: 18789069
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma.
Evangelista MT; North JP
J Cutan Pathol; 2015 Nov; 42(11):824-31. PubMed ID: 26016446
[TBL] [Abstract][Full Text] [Related]
5. Hierarchical Cluster Analysis of Cytokeratins and Stem Cell Expression Profiles of Canine Cutaneous Epithelial Tumors.
Kok MK; Chambers JK; Ong SM; Nakayama H; Uchida K
Vet Pathol; 2018 Nov; 55(6):821-837. PubMed ID: 30071783
[TBL] [Abstract][Full Text] [Related]
6. Expression of stem cell markers nestin and cytokeratin 15 and 19 in cutaneous malignancies.
Abbas O; Bhawan J
J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):311-6. PubMed ID: 20629844
[TBL] [Abstract][Full Text] [Related]
7. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
Sellheyer K; Nelson P; Kutzner H; Patel RM
J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
[TBL] [Abstract][Full Text] [Related]
8. Merkel cell-poor trichoblastoma with basal cell carcinoma-like foci.
Misago N; Satoh T; Miura Y; Nagase K; Narisawa Y
Am J Dermatopathol; 2007 Jun; 29(3):249-55. PubMed ID: 17519622
[TBL] [Abstract][Full Text] [Related]
9. Expression of CXCR4 is associated with progression and invasion in patients with nasal-surface basal cell carcinoma.
Xu CZ; Wang PH; Yan XJ; Wang T; Chen D; Zhang ZJ; Shi RJ
ORL J Otorhinolaryngol Relat Spec; 2013; 75(6):332-41. PubMed ID: 24401734
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical FHIT expression still exists in early lesions of basal cell carcinoma.
Kiyici H; Bilezikçi B; Ozen O; Demirhan B
Pathol Res Pract; 2010 Jul; 206(7):445-9. PubMed ID: 20399571
[TBL] [Abstract][Full Text] [Related]
11. Basal cell carcinoma: CD56 and cytokeratin 5/6 staining patterns in the differential diagnosis with Merkel cell carcinoma.
Panse G; McNiff JM; Ko CJ
J Cutan Pathol; 2017 Jun; 44(6):553-556. PubMed ID: 28403527
[TBL] [Abstract][Full Text] [Related]
12. Rippled-pattern basal cell carcinoma.
Misago N; Tsuruta N; Narisawa Y
J Dermatol; 2012 Jul; 39(7):632-5. PubMed ID: 22211777
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin 19 expression in normal endometrium and in low-grade endometrioid adenocarcinoma of the endometrium.
Stewart CJ; Crook ML; Lacey J; Louwen K
Int J Gynecol Pathol; 2011 Sep; 30(5):484-91. PubMed ID: 21804393
[TBL] [Abstract][Full Text] [Related]
14. Basal cell tumor in a Japanese macaque (Macaca fuscata).
Yanai T; Wakabayashi S; Masegi T; Iwasaki T; Yamazoe K; Ishikawa K; Ueda K
Vet Pathol; 1995 May; 32(3):318-20. PubMed ID: 7604501
[TBL] [Abstract][Full Text] [Related]
15. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 17 is highly sensitive in discriminating cutaneous lymphadenoma (a distinct trichoblastoma variant) from basal cell carcinoma.
Goyal A; Solus JF; Chan MP; Doyle LA; Schaffer A; Thakuria M; Horn TD; Duncan LM; Nazarian RM
J Cutan Pathol; 2016 May; 43(5):422-9. PubMed ID: 26968559
[TBL] [Abstract][Full Text] [Related]
17. High-grade trichoblastic carcinosarcoma.
Kazakov DV; Vittay G; Michal M; Calonje E
Am J Dermatopathol; 2008 Feb; 30(1):62-4. PubMed ID: 18212548
[TBL] [Abstract][Full Text] [Related]
18. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
19. [Specific characteristics of skin basal cell carcinoma invasion].
Doĭkova NG; Chernyĭ AP; Chipysheva TA; Gel'shteĭn VI
Arkh Patol; 2000; 62(3):29-33. PubMed ID: 10897434
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
